Pharma IQ Members

Antibody Production

Antibody Production, for example, is when animals produce antibodies in response to proteins or other molecules (termed immunogens) recognized as foreign by their immune system. The antibodies are secreted into the plasma by B cells that are able to interact with the immunogen. The intensity of the response is determined by several factors including the size of the immunogen molecule, its chemical characteristics, and how different it is from the animal's own proteins. Most natural immunogens are proteins. The antibody response increases with repeated exposure to the immunogen, so a series of injections at regular intervals is needed to achieve both high levels of antibody production and antibodies of high affinity.

17 results
of 2
Eric Langer

Key areas driving demand for single-use applications

Single-use applications continue to dominate the list of innovation areas sought by the biopharmaceutical manufacturing community, a testament to the widespread optimism surrounding the...

Contributor: Eric Langer
Mon, 10/26/2015
Trends and Successes in Disposable Tech

“Changes in lifestyles and healthcare systems, and increasing demand for drugs at reduced prices, has led to the development of facilities that can produce more than one product, offering flexibility and scalability.” (4) Single use systems,...

Contributor: Chanice Henry
Mon, 09/28/2015
Top 10 Disruptive Technologies in Pharma

When it comes to market innovation, providers tend to split into two camps, the disrupters and the disrupted. Technological advancement is an arena that sees many attempts at sparking revolution. With this in mind, Pharma IQ takes a look at 10 of...

Contributor: Chanice Henry
Thu, 05/28/2015
Pharma IQ News

Jones Lang LaSalle reports the key considerations for transforming existing facilities to meet the rising demand for biologic medicinesTraditional pharmaceutical manufacturing facilities are being driven into dinosaur status as demand grows for...

Contributor: Pharma IQ News
Mon, 10/21/2013
Pharma IQ News
Moderate Growth Rate and Increasing Competition for the Therapeutic Proteins Market

The global therapeutic proteins market will grow at a moderate pace, with monoclonal antibodies considered to be the highest revenue generating market in 2010....

Contributor: Pharma IQ News
Mon, 10/03/2011
Cristina Falcão

What were the odds that the drug makers would roll the dice and have not only a financial mega hit but in Mergers & Acquisitions and Offshore-Production two “star is born “stories in a single show? The whole world is moving to more connected...

Contributor: Cristina Falcão
Tue, 08/16/2011
Eric Langer

Single use technologies are strong change agents in biopharma manufacturing.  Disposable devices emerge once again as a top new technology of interest among the 352 surveyed biomanufacturers in BioPlan Associates, Inc.’s 2011 8th Annual Report...

Contributor: Eric Langer
Mon, 08/08/2011
Cost Savings Still the Number One Reason Behind 60% of Outsourced Pharma and Bio Manufacturing

While there is normally more than one factor behind the decision of a pharmaceutical or biopharmaceutical organisation to outsource its global manufacturing, it seems the ever-important cost-saving potential remains among the main attraction of...

Contributor: Pharma IQ
Sun, 05/15/2011
Eric Langer

During the past six years, single use systems and devices have emerged as a key change agent in the biomanufacturing landscape. Acceptance in R&D and scale-up has been driven by their effectiveness in reducing risks of contamination, faster...

Contributor: Eric Langer
Mon, 04/04/2011
Pharma IQ

Unwanted immunogenicity can often result in projects being cancelled or severely delayed, to the substantial cost of the developer, and so ensuring this particular process goes smoothly is at the forefront of industry leaders' minds. One...

Contributor: Pharma IQ
Mon, 02/21/2011
17 results
of 2